After reviewing the historical use of ADCs, panelists discuss the first patient profile of HER2+ metastatic breast cancer managed with trastuzumab deruxtecan.
Stay up to date on recent advances in oncology nursing and patient care.
Acupuncture Use in BC Predicted by Social Determinants of Health
ctDNA Monitoring is a Piece of the Puzzle in CRC Treatment
Holly Chitwood, DNP, FNP-C, AGACNP-BC, explains how circulating tumor DNA monitoring helps providers screen minimal residual disease in individuals with colorectal cancer.
Tailored Intervention Aids Distress, Recovery After Breast-Conserving Surgery
Assessment of psychological needs and offering tailored interventions immediately after BCS helps patients with breast cancer in the outpatient setting.
Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses
Ryan Tamargo, NP, AONCP, discusses the launch of an online inflammatory breast cancer scoring system tool.
Social Health Determinants Impact Psychoneurological Symptoms in BC Survivors
Social determinants of health like transportation and financial increased the occurrence of psychoneurological symptoms in breast cancer survivors.
Cabozantinib Approved for Unresectable, Advanced/Metastatic epNET and pNET
The FDA approved cabozantinib for use in patients with previously treated unresectable, locally advanced or metastatic, well-differentiated epNETs or pNETs.
Cilta-Cel Improves QOL, Extends Treatment Breaks vs SOC in R/R Myeloma
Variability Found in PROs, Gene Expression During AML Induction Chemo
Blinatumomab-Linked ICANS Cases Higher Than Previously Reported